Other
Stress Response
0
Pipeline Programs↗
1
Active Trials↗
1
Companies Involved↗
Stress Response is an early-stage landscape with 0 programs across 1 company. The most active players are CeNeRx BioPharma Inc..
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
14
clinical trials
Completed8 · 57%
Unknown status3 · 21%
Withdrawn1 · 7%
Suspended1 · 7%
Recruiting1 · 7%
Clinical Trials
Trial Activity
14 trials
Oxytocin Buffers Stress Response in Individuals With Impaired Coping Abilities
Completed·—·N/A·NCT01065610
Lignocaine Nebulization for Attenuation of Intubation Stress Response
Unknown status·—·Phase 4·NCT04441073·100 enrolled
Comparison Between IV Propofol and Propofol/ Fentanyl Anesthesia on Patients Stress Response
Unknown status·—·Phase 2/3·NCT03143933·40 enrolled
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)